Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.16.

  • Biodesix's EPS (Basic) rose 1714.29% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 33157.89%. This contributed to the annual value of -$0.33 for FY2024, which is 4847.98% up from last year.
  • Biodesix's EPS (Basic) amounted to -$1.16 in Q3 2025, which was up 1714.29% from -$0.08 recorded in Q2 2025.
  • Biodesix's 5-year EPS (Basic) high stood at -$0.06 for Q4 2024, and its period low was -$4.52 during Q2 2021.
  • Over the past 5 years, Biodesix's median EPS (Basic) value was -$0.26 (recorded in 2021), while the average stood at -$0.57.
  • As far as peak fluctuations go, Biodesix's EPS (Basic) surged by 9930.07% in 2021, and later crashed by 90000.0% in 2024.
  • Biodesix's EPS (Basic) (Quarter) stood at -$0.49 in 2021, then skyrocketed by 32.65% to -$0.33 in 2022, then soared by 72.73% to -$0.09 in 2023, then rose by 28.01% to -$0.06 in 2024, then tumbled by 1690.47% to -$1.16 in 2025.
  • Its EPS (Basic) was -$1.16 in Q3 2025, compared to -$0.08 in Q2 2025 and -$0.08 in Q1 2025.